Our patient received vedolizumab, anti-TNF therapy (infliximab), azathioprine, and a short period of prednisone during his illness, and was recently diagnosed with B-ALL with BCR-ABL(t9-22) positive. This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.